Literature DB >> 20424624

Hyperkalemia: a threat to RAAS inhibition?

Robert W Schrier.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20424624     DOI： 10.1038/nrneph.2010.52

Source DB:  PubMed          Journal:  Nat Rev Nephrol        ISSN： 1759-5061            Impact factor:   28.314


× No keyword cloud information.
  7 in total

1.  Adherence to heart failure quality-of-care indicators in US hospitals: analysis of the ADHERE Registry.

Authors:  Gregg C Fonarow; Clyde W Yancy; J Thomas Heywood
Journal:  Arch Intern Med       Date:  2005-07-11

2.  The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators.

Authors:  B Pitt; F Zannad; W J Remme; R Cody; A Castaigne; A Perez; J Palensky; J Wittes
Journal:  N Engl J Med       Date:  1999-09-02       Impact factor: 91.245

Review 3.  Potassium homeostasis and renin-angiotensin-aldosterone system inhibitors.

Authors:  Matthew R Weir; Mark Rolfe
Journal:  Clin J Am Soc Nephrol       Date:  2010-02-11       Impact factor: 8.237

4.  Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study.

Authors:  David N Juurlink; Muhammad M Mamdani; Douglas S Lee; Alexander Kopp; Peter C Austin; Andreas Laupacis; Donald A Redelmeier
Journal:  N Engl J Med       Date:  2004-08-05       Impact factor: 91.245

5.  Serum potassium and clinical outcomes in the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS).

Authors:  Bertram Pitt; George Bakris; Luis M Ruilope; Lorenzo DiCarlo; Robin Mukherjee
Journal:  Circulation       Date:  2008-09-29       Impact factor: 29.690

6.  Neurologic sequelae after treatment of severe hyponatremia: a multicenter perspective.

Authors:  R H Sterns; J D Cappuccio; S M Silver; E P Cohen
Journal:  J Am Soc Nephrol       Date:  1994-02       Impact factor: 10.121

7.  Predictors of hyperkalemia risk following hypertension control with aldosterone blockade.

Authors:  Nitin Khosla; Rigas Kalaitzidis; George L Bakris
Journal:  Am J Nephrol       Date:  2009-09-09       Impact factor: 3.754
  7 in total
  1 in total

1.  Prescription patterns of sodium and calcium polystyrene sulfonate in patients with hyperkalemia and chronic kidney disease receiving RAAS inhibitors.

Authors:  Hongru Ren; Silvia J Leon; Reid Whitlock; Claudio Rigatto; Paul Komenda; Clara Bohm; David Collister; Navdeep Tangri
Journal:  Clin Kidney J       Date:  2022-03-21
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.